Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be “sub-standard or found to be containing toxins”, reports Sohini Das.......
The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in......
Australia on Monday announced easing of its stringent pandemic-related travel restrictions from next month, a decision that is expected to help thousands of Indian students return to that country.......
Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's border was reopened for the first time in......
Calling for 'equal recognition of vaccines', COVAX on Thursday urged all governments to recognise as 'fully vaccinated' those people who have received COVID-19 vaccines deemed safe by World Health......
Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country......
Stressing that it has rectified past "shortcomings" and its drugs are safe and efficacious, Ranbaxy Laboratories on Thursday said it will co-operate fully with any regulator from anywhere in the......
Four years after being banned by the United States Food and Drug Administration, Ranbaxy Laboratories said on Monday it has resumed exports of finished drugs to the US with the commencement of......
Drug major Ranbaxy on Wednesday said it has received approval from the Australian health regulator to market its antipsychotic drug Ozidal Risperidone in that country. Ranbaxy Australia, the wholly......
Australian health regulator Therapeutic Goods Administration is investigating Indian pharma major Ranbaxy, following US allegations of the company falsifying data and test results of new drug......